¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"SAR : structure activity relationship"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® doctor-patient relationship ÇÑ±Û ÀÇ»çȯÀÚ°ü°è
¼³¸í   
  »çȸÀûÀ¸·Î ±â´ëµÇ´Â °¢ ¿ªÇÒ¿¡ µû¸¥ »óÈ£ÇàÀ§¸¦ ÅëÇØ¼­ ÀÇ»ç¿Í È¯ÀÚ°¡ ¸Î´Â °ü°è. ÀÇ»ç-ȯÀÚ°ü°è´Â, ¨ç ´Éµ¿Àû-¼öµ¿Àû°ü°è, ¨è Áöµµ-Çù·Â°ü°è, ¨é »óÈ£Âü°¡°ü°èÀÇ ¼¼ °¡Áö·Î À¯ÇüÈ­ÇÒ ¼ö ÀÖ´Ù. Áúº´±¸Á¶ÀÇ Áß½ÉÀÌ ±Þ¼º Áúȯ¿¡¼­ ¸¸¼ºÁúȯÀ¸·Î ÀÌÇàÇϴ °¡¿îµ¥ ÀÇ»ç-ȯÀÚ°ü°èµµ ¨ç¿¡¼­ ¨éÀ¸·Î ¹Ù²î´Â °ÍÀÌ ¿ä±¸µÇ°í ÀÖ´Ù. ±×·¯³ª ÀϹæÀûÀ¸·Î ÀÏÇϴ ÀÇ»ç¿Í Áö½Ã¿¡ µû¸£±â¸¸ Çϴ ¼öµ¿Àû È¯ÀÚ¿ÍÀÇ °ü°è´Â ¾ÆÁ÷µµ »Ñ¸®±í°Ô ³²¾ÆÀÖ´Ù. ¶Ç ÃÖ±ÙÀÇ ÀÇ·á±â°èÈ­´Â ÀÇ»ç¿Í È¯ÀÚ°¡ ±â°è¸¦ ¸Å°³·Î Çؼ­ °£Á¢ÀûÀ¸·Î »óÈ£¿¬°üµÇ´Â »õ·Î¿î °ü°è±îÁöµµ ³º°í ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • structure activity relationship
    ±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
  • alveolar structure
    1. ²Ê¸®±¸Á¶, ÆóÆ÷±¸Á¶ 2. Æ÷»ó±¸Á¶
  • cognitive structure
    ÀÎÁö±¸Á¶
  • structure
    1. ±¸Á¶ 2. Á¶Á÷ 3. ±¸Á¶¹°
  • causal relationship
    Àΰú°ü°è
  • child-parent relationship
    ¾î¸°À̺θð°ü°è
  • doctor-patient relationship
    ÀÇ»çȯÀÚ°ü°è
  • dose-response relationship
    ¿ë·®¹ÝÀÀ°ü°è
  • relationship
    °ü°è
  • symbiotic relationship
    °ø»ý°ü°è
  • working relationship
    ÀÛ¾÷°ü°è
  • antibacterial activity
    Ç×±ÕÀÛ¿ë
  • activity
    1. Ȱ¼ºµµ 2. Ȱµ¿, Ȱ¼º 3. -´É
  • biologic activity
    »ý¹°ÇÐÀûȰ¼º
  • caries activity
    ¿ì½ÄȰµ¿
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱ¼ºµµ, Ȱµ¿
  • specific activity
    ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
  • relationship
    °ü°è
  • doctor-patient relationship
    ÀÇ»çȯÀÚ°ü°è
  • dose-response relationship
    ¿ë·®¹ÝÀÀ°ü°è
  • structure
    ±¸Á¶
  • alveolar structure
    ²Ê¸®±¸Á¶, ÆóÆ÷±¸Á¶
  • bone structure
    »À±¸Á¶, °ñ±¸Á¶
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • structure activity relationship
    ±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
  • causal relationship
    Àΰú°ü°è
  • child-parent relationship
    ¾î¸°À̺θð°ü°è
  • doctor-patient relationship
    ÀÇ»çȯÀÚ°ü°è
  • dose response relationship
    ¿ë·®¹ÝÀÀ°ü°è
  • host-parasite relationship
    ¼÷ÁÖ±â»ýü»óÈ£°ü°è
  • relationship
    °ü°è
  • symbiotic relationship
    °ø»ý°ü°è
  • time dose relationship
    ½Ã°£¿ë·®°ü°è
  • working relationship
    ÀÛ¾÷°ü°è
  • adnexal structure
    ºÎ¼Ó±¸Á¶
  • alveolar structure
    ²Ê¸®±¸Á¶, ÆóÆ÷±¸Á¶
  • bone structure
    »À±¸Á¶, °ñ±¸Á¶
  • chain structure
    »ç½½±¸Á¶, ¿¬¼â±¸Á¶
  • cognitive structure
    ÀÎÁö±¸Á¶
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SAR : structure activity relationship
    ±¸Á¶ÀÛ¿ë°ü°è.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Larmor relationship
    ¶ó¸ð °ü°è
  • alveolar structure
    Æ÷»ó±¸Á¶(¡­Ï°ðã).
  • alveolar structure
    ÆóÆ÷±¸Á¶(¡­Ï°ðã)
  • antibody structure
    Ç×ü±¸Á¶(¡­Ï°ðã).
  • antigenic structure
    Ç׿ø±¸Á¶(¡­Ï°ðã).
  • helical structure
    ³ª¼±±¸Á¶(¡­Ï°ðã).
  • hemochorial structure
    Ç÷¾×À¶¸ð¸·±¸Á¶
  • hemodichorial structure
    Ç÷¾×µÎÃþÀ¶¸ð¸·±¸Á¶
  • hemoglobin structure
    Ç÷»ö¼Ò±¸Á¶
  • hemomonochorial structure
    Ç÷¾×ȬÃþÀ¶¸ð¸·±¸Á¶
  • immunoglobulin structure
    ¸é¿ª±Û·ÎºÒ¸° ±¸Á¶
  • personality structure, Jungian theory
    Àΰݱ¸Á¶
  • primary structure
    ÀÏÂ÷±¸Á¶(¡­Ï°ðã).
  • pseudoknot RNA structure
    ¸ÅµìÇü RNA ±¸Á¶
  • quasicrystalline structure
    ÁذáÁ¤±¸Á¶(ñÞÌ¿ïÜϰðã).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • structure activity relationship
    ±¸Á¶-Ȱ¼ºµµ°ü°è.
  • structure activity relationship
    (È­ÇÐ)±¸Á¶ Ȱ¼º »ó°ü°ü°è
  • scatter-air ratio, SAR
    »ê¶õ°ø±âºñ
  • specific absorption rate (SAR)
    ƯÀÌ Èí¼öÀ²
  • specific absorption ratio, SAR
    Ư¼ºÈí¼öÀ²
  • causal relationship
    Àΰú°ü°è(ËöË­Ë´Ë­).
  • child-parent relationship
    ¼Ò¾Æ¾çÄ£°ü°è.
  • doctor-patient relationship
    ÀÇ»çȯÀÚ(½Å·Ú)°ü°è(ì¢ÞÔü´íºãá μÌõ).
  • doctor-patient relationship
    ÀÇ»çȯÀÚ(½Å·Ú)°ü°è(ËöË×Ì·ËöËà Ë´Ë­).
  • doctor-patient relationship
    ÀÇ»çȯÀÚ°ü°è(ì¢ÞÔü´íºãá μÌõ).
  • dose response curve/relationship
    ¿ë·®-¹ÝÀÀ°î¼±/°ü°è.
  • dose response relationship
    ¹æ»ç ¾à¸®,»ý¸®,»ýÈ­,ÇÙÀǿ뷮¹ÝÀÀ°ü°è (¡­Î¼Ìõ).
  • dose-effect relationship
    ¼±·®¿µÇâ°ü°è
  • dose-response relationship
    ¼±·®¹ÝÀÀ°ü°è
  • host-parasite relationship
    ¼÷ÁÖ-±â»ýü »óÈ£°ü°è
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Intra-articular structure
    °üÀý¼Ó±¸Á¶¹°
    [¿¾ ¿ë¾î] °üÀý³»±¸Á¶
  • Typical structure
    ÀüÇüÀû±¸Á¶
    [¿¾ ¿ë¾î] ÀüÇüÀû±¸Á¶
  • Decidua structure
    Å»¶ô¸·±¸Á¶
    [¿¾ ¿ë¾î] Å»¶ô¸·±¸Á¶
  • Hemodichorial structure
    Ç÷¾×µÎÃþÀ¶¸ð¸·±¸Á¶
    [¿¾ ¿ë¾î] Ç÷ÀÌÀ¶¸ð¸·¼º±¸Á¶
  • Hemochorial structure
    Ç÷¾×À¶¸ð¸·±¸Á¶
    [¿¾ ¿ë¾î] Ç÷À¶¸ð¸·¼º±¸Á¶
  • Hemomonochorial structure
    Ç÷¾×ȬÃþÀ¶¸ð¸·±¸Á¶
    [¿¾ ¿ë¾î] Ç÷´ÜÀ¶¸ð¸·¼º±¸Á¶
  • Discoid structure
    ¿ø¹Ý±¸Á¶
    [¿¾ ¿ë¾î] ¿ø¹Ý»ó±¸Á¶
  • Villous structure
    À¶¸ð±¸Á¶
    [¿¾ ¿ë¾î] À¶¸ð±¸Á¶
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • host parasite relationship
    ¼÷ÁÖ±â»ýÃæ°ü°è
  • symbiotic relationship
    °ø¼­»ýȰ°ü°è
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱ·®(üÀÕá)
  • activity
    Ȱ¼º (üÀàõ)
  • activity coefficient
    Ȱ·®°è¼ö (üÀÕá°èâ¦)
  • catalytic center activity
    Ã˸ÅÁß½É È°¼º(õºØÚñéãýüÀàõ)
  • concentration of enzymatic activity
    È¿¼ÒȰ¼º ³óµµ(ý£áÈüÀàõÒØÓø)
  • enzymatic activity
    È¿¼Ò Ȱ¼º (ý£áÈüÀàõ)
  • intrinsic activity
    ³»ÀçȰ¼º(Ò®î¤üÀàõ)
  • mean activity coefficient
    Æò±ÕȰµ¿°è¼ö(øÁгüÀÔÑͪâ¦)
  • mean ionic activity coefficient
    Æò±Õ(øÁг) ÀÌ¿ÂȰ¼º°è¼ö(üÀàõͪâ¦)
  • molar activity
    ¸ô Ȱ¼º(üÀàõ)
  • molecular activity
    ºÐÀÚȰ¼º(ÝÂí­üÀàõ)
  • myotropic activity
    ±Ù°­È­È°¼º(ÐÉË­ûùüÀàõ)
  • optical activity
    ±¤ÇРȰ¼º(ÎÃùÊüÀàõ)
  • Raman optical activity
    ¶ó¸¸ ±¤ÇРȰ¼º(µµ)(ÎÃùÊüÀàõ(Óø))
  • relative specific activity
    »ó´ë ƯÀÌ È°¼ºµµ(ßÓÓß÷åì¶üÀàõÓø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱ¼ºµµ, Ȱµ¿µµ
  • Larmor relationship
    ¶ó¸ð °ü°è
  • specific absorption rate [=SAR]
    ƯÀÌÈí¼öÀ²
  • core structure
    Á᫐ ±¸Á¶¹°
  • helical structure
    ³ª¼±±¸Á¶
  • structure
    ±¸Á¶
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SAR scatter/air ratio; seasonal allergic rhinitis; sexual attitude reassessment; slowly adapting recepto...
QSAR quantitative structure-activity relationship
NYHA New York Heart Association
  Heart Disease¿¡ ´ëÇÑ Functional Classification
 &nbs...
Sar sulfarsphenamine
ISA Instrument Society of America; intracarotid sodium amytal; intrinsic simulating activity; intrinsic ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SAR Structure activity relationship
QSAR Quantitative Structure Activity Relationship
3-D-QSAR Three-dimensional quantitative structure-activity relationship
QSPR Quantitative Structure-Property Relationship
CCRT Core Conflictual Relationship Theme
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • SAR
    ±¸Á¶ ÀÛ¿ë °ü°è
  • causal relationship
    Àΰú °ü°è
  • doctor-patient relationship
    ÀÇ»ç-ȯÀÚ °ü°è, ÀÇ»ç ȯÀÚ ½Å·Ú °ü°è
  • dose response relationship
    ¹æ»ç¿ë·® ¹ÝÀÀ °ü°è, ¿ë·® ¹ÝÀÀ °ü°è
  • dose-effect relationship
    ¼±·® ¿µÇâ °ü°è
  • end to end relationship
    Àý´Ü¸é°ú Àý´Ü¸é °ü°è
  • host-parasitite relationship
    ¼÷ÁÖ-±â»ýüÀÇ »óÈ£ °ü°è
  • intercuspal position relationship
    ±³µÎ°£À§ °ü°è
  • interpersonal relationship
    ´ëÀÎ °ü°è
  • jawcranial base relationship
    ¾Ç°ñ µÎ°³ÀúÀÇ °ü°è
  • maladaptive biomechanical relationship
    ºñÀûÀÀ¼º »ý¿ªÇÐÀû °ü°è
  • maxillomandibular relationship
    »óÇÏ¾Ç °ü°è
  • open occlusal relationship
    °³±¸ ±³ÇÕ °ü°è
    ±³ÇÕÇÏ´Â À§Ä¡¿¡¼­ Ä¡¾Æ Á¢ÃËÀÇ °á¿©.
  • posterior open occlusal relationship
    ±¸Ä¡ À̰³ ±³ÇÕ °ü°è
  • segmental relationship
    ºÐÀý °ü°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
structure-activity relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Other factors contributing to structure-activity relationship include chemical reactivity, electronic effects, resonance, and inductive effects.
(12 Dec 1998)
structure activity analysis Study in which systematic variation in the structure of a compound is correlated with its activity, in an attempt to determine the characteristics of the (receptor) site at which it acts.
(18 Nov 1997)
Sar <abbreviation> Scaffold-associated regions.
<abbreviation> Sarcosine.
(05 Mar 2000)
blood relationship A relationship that share a common bloodline, descent from a common ancestor.
(27 Sep 1997)
relationship The state of being related, associated, or connected.
(05 Mar 2000)
coefficient of relationship The probability that a gene present in one mate is also present in the other and is derived from the same source.
(05 Mar 2000)
Haldane relationship <biochemistry> A mathematical relationship between the equilibrium constant of an enzyme-catalyzed reaction and all of that enzyme's kinetic parameters (e.g., Vmax and Km's).
(05 Mar 2000)
sadomasochistic relationship A relationship characterised by the complementary enjoyment of inflicting and suffering cruelty.
(05 Mar 2000)
hypnotic relationship Relationship between hypnotiser, or hypnotist, and the hypnotised, or hypnotee.
(05 Mar 2000)
dose-response relationship Relationship in which a change in the amount, intensity, or duration of exposure is associated with a change in risk of a specified outcome.
(05 Mar 2000)
dose-response relationship, drug The relationship between the dose of an administered drug and the response of the organism to the drug.
(12 Dec 1998)
dose-response relationship, immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell.
(12 Dec 1998)
dose-response relationship, radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation.
(12 Dec 1998)
object relationship In the behavioural sciences, the emotional bond between an individual and another person (or between two groups), as opposed to the individual's (or group's) interest in him or herself (itself).
(05 Mar 2000)
activity 1. The state of being active, the ability to produce some effect, the extent of some function or action.
2. <chemistry> A thermodynamic quantity that represents the effective concentration of a solute in a nonideal solution, if concentrations are replaced by activities, the equations for equilibrium constants, electrode potentials, osmotic pressure, boiling point elevation, freezing point depression and vapour pressures of volatile solutes are converted from approximations that hold only for dilute solutions to exact equations that hold for all concentrations. The activity is equal to the product of the concentration and the activity coefficient, a dimensionless number measuring deviation from nonideality. Symbol a.
The potential or true thermodynamic activity of a substance, as opposed to its molar concentration.
3. <radiobiology> The number of nuclear transitions or disintegrations occurring in a given quantity of radioactive material per unit time. The SI unit of activity is s-1. The special name for the unit of activity is becquerel (Bq). The previously used special unit of activity, curie (Ci), is being replaced by the becquerel. 1 Bq = 2.7 x E-11 Ci. 1 Ci = 3.7 x E10 Bq.
4. Optical activity.
(16 Dec 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • relationship
    Ä£Á·°ü°è
  • relationship
    °ü°è;ģô°ü°è 
  • activity
    Ȱµ¿,Ȱ±â
  • activity
    Ȱµ¿;Ȱ¾à;Ȱ±â;ȰȲ;´Éµ¿¼º;Ȱµ¿¹üÀ§
  • crew activity planning
    (¿ìÁÖ¼± ºñÇàÁßÀÇ) ½Â¹«¿ø ÀÛ¾÷°èȹ
  • extracurricular activity
    °ú¿Ü Ȱµ¿;(¼Ó)ºÎÁ¤(ºÎµµ´ö)ÇàÀ§;¿Üµµ
  • extravehicular activity
    (¿ìÁÖÀÎÀÇ)¼±¿Ü Ȱµ¿
  • structure
    ±¸Á¶,Á¶Á÷,°ÇÃà(¹°)
  • constituent structure
    ±¸¼º¿ä¼Ò ±¸Á¶
  • cryptoexplosion structure
    ÀǺÐÈ­ ±¸Á¶
  • deep structure
    ½ÉÃþ ±¸Á¶((º¯Çü)»ý¼º ¹®¹ý¿¡¼­ ¹®ÀåÀÇ Àǹ̸¦ °áÁ¤ÇÏ´Â ½É¸®Àû ½ÇÀç·Î¼­ÀÇ ±âÀú ±¸Á¶)
  • fine structure
    ¹Ì¼¼±¸Á¶
  • molecular structure
    ºÐÀÚ ±¸Á¶
  • phrase structure grammar
    ±¸±¸Á¶ ¹®¹ý
  • power structure
    ±Ç·Â ±â±¸
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á